| Theme | Clinical practice guideline for CKD-MBD | |
|---|---|---|
| Title | Importance of sequential management of CKD-MBD in kidney transplant recipients from dialysis period through transplantation | |
| Publish Date | 2012/10 | |
| Author | Naohiko Fujii | Research and Medical Center for Kidney Disease and Transplantation, Hyogo Prefectural Nishinomiya Hospital |
| Author | Ayako Okuno | Research and Medical Center for Kidney Disease and Transplantation, Hyogo Prefectural Nishinomiya Hospital |
| Author | Sayoko Yonemoto | Research and Medical Center for Kidney Disease and Transplantation, Hyogo Prefectural Nishinomiya Hospital |
| Author | Kenji Nishimura | Research and Medical Center for Kidney Disease and Transplantation, Hyogo Prefectural Nishinomiya Hospital |
| Author | Hidefumi Kishikawa | Research and Medical Center for Kidney Disease and Transplantation, Hyogo Prefectural Nishinomiya Hospital |
| Author | Yasuji Ichikawa | Research and Medical Center for Kidney Disease and Transplantation, Hyogo Prefectural Nishinomiya Hospital |
| [ Summary ] | The pathophysiology of CKD-MBD in kidney transplant recipients (KTRs) is multifactorial. It never starts after kidney transplantation. However, it emerges in the pre-transplant dialysis period. Given that we have no established treatment for CKD-MBD in KTRs in the posttransplant period, the management of CKD-MBD from the dialysis period through transplantation should certainly be regarded as a practical and effective measure. In this article, the possible mechanisms of CKD-MBD in KTRs and the new Japanese guidelines for CKD-MBD in KTRs are introduced. | |